Weimin Kong

2.2k total citations · 2 hit papers
49 papers, 1.5k citations indexed

About

Weimin Kong is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Weimin Kong has authored 49 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 15 papers in Immunology and 12 papers in Molecular Biology. Recurrent topics in Weimin Kong's work include CAR-T cell therapy research (8 papers), Drug Transport and Resistance Mechanisms (8 papers) and Immune Cell Function and Interaction (6 papers). Weimin Kong is often cited by papers focused on CAR-T cell therapy research (8 papers), Drug Transport and Resistance Mechanisms (8 papers) and Immune Cell Function and Interaction (6 papers). Weimin Kong collaborates with scholars based in United States, China and United Kingdom. Weimin Kong's co-authors include Doina Ganea, Joseph A. Fraietta, Erik F. Williams, Michael C. Milone, Jui‐Hung Yen, Ronald F. Tuma, Hongbo Li, Miguel G. Toscano, Sabina Adhikary and Evros Vassiliou and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Immunity.

In The Last Decade

Weimin Kong

48 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An introduction to chimeric antigen receptor (CAR) T‐cell immunotherapy for human cancer

2019 420 citations Weimin Kong, Joseph A. Fraietta et al. profile →
Deletion of the inhibitory co-receptor CTLA-4 enhances and invigorates chimeric antigen receptor T cells

2023 104 citations Weimin Kong, Joseph A. Fraietta et al. profile →

Peers

Countries citing papers authored by Weimin Kong

Since Specialization

Citations

This map shows the geographic impact of Weimin Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weimin Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weimin Kong more than expected).

Fields of papers citing papers by Weimin Kong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weimin Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weimin Kong. The network helps show where Weimin Kong may publish in the future.

Co-authorship network of co-authors of Weimin Kong

This figure shows the co-authorship network connecting the top 25 collaborators of Weimin Kong. A scholar is included among the top collaborators of Weimin Kong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weimin Kong. Weimin Kong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sacituzumab govitecan in Chinese patients with recurrent/metastatic cervical cancer: Results from the phase 2 EVER-132-003 basket study (NCT05119907) 2025 ·Gynecologic Oncology ·Jusheng An, Guiling Li, Jennifer Zhang, Mei Feng, Weimin Kong, Haiping Jiang, Suxia Luo, Wei Li, (unknown), Ling Han, (unknown), Simonetta Mocci, Yi‐Lin Yan, Lingying Wu	1
2	Global burden, trends and inequalities of maternal hypertensive disorders among reproductive-age women of advanced maternal age, 1990–2021: a population-based study 2025 ·Frontiers in Global Women s Health ·Xue Zhao, Weimin Kong, Yan Jiang, F. F. Sui	3
3	Bile duct ligation increased dopamine levels in the cerebral cortex of rats partly due to induction of tyrosine hydroxylase 2023 ·British Journal of Pharmacology ·Weimin Kong, (unknown), Siyu Yu, Peihua Liu, Xiaoke Zheng, Jiaxin Zhang, Liang Zhu, (unknown), Mengmeng Jin, (unknown), Xiaomin Fan, Xiaodong Liu, Li Liu	10
4	Enhanced Costimulatory Signaling Improves CAR T-cell Effector Responses in CLL 2022 ·Cancer Research Communications ·McKensie Collins, In-Young Jung, Ziran Zhao, (unknown), Weimin Kong, Stefan Lundh, Joseph A. Fraietta, Arnon P. Kater, Clare Sun, Adrian Wiestner, J. Joseph Melenhorst	11
5	A Whole-Body Physiologically Based Pharmacokinetic Model Characterizing Interplay of OCTs and MATEs in Intestine, Liver and Kidney to Predict Drug-Drug Interactions of Metformin with Perpetrators 2021 ·Pharmaceutics ·(unknown), (unknown), Ping Li, Weimin Kong, Xiaodong Liu, Li Liu	11
6	PXR activation impairs hepatic glucose metabolism partly via inhibiting the HNF4α–GLUT2 pathway 2021 ·Acta Pharmaceutica Sinica B ·Peihua Liu, (unknown), Weimin Kong, (unknown), Ping Li, Xiaonan Liu, (unknown), (unknown), Ming Liu, Zhongjian Wang, Liang Zhu, Hanyu Yang, Ying Zhou, Jianjun Zou, (unknown), (unknown), Li Liu	30
7	Bile duct ligation causes opposite impacts on the expression and function of BCRP and P-gp in rat brain partly via affecting membrane expression of ezrin/radixin/moesin proteins 2021 ·Acta Pharmacologica Sinica ·Tong Wu, Sheng Yun, Yuanyuan Qin, Weimin Kong, Mengmeng Jin, Hanyu Yang, Xiaoke Zheng, Chang Dai, Ming Liu, Xiaodong Liu, Li Liu	14
8	Hepatic Ischemia-Reperfusion Impairs Blood-Brain Barrier Partly Due to Release of Arginase From Injured Liver 2021 ·Frontiers in Pharmacology ·Liang Zhu, (unknown), Feng Xu, Hanyu Yang, Ping Li, Sheng Yun, Peihua Liu, Weimin Kong, Xiaonan Liu, Yang Lu, Li Liu, Xiaodong Liu	12
9	Physiologically based pharmacokinetic–pharmacodynamic modeling for prediction of vonoprazan pharmacokinetics and its inhibition on gastric acid secretion following intravenous/oral administration to rats, dogs and humans 2020 ·Acta Pharmacologica Sinica ·Weimin Kong, Binbin Sun, Zhongjian Wang, Xiaoke Zheng, Kaijing Zhao, Chen Yang, Jiaxin Zhang, (unknown), Liang Zhu, Rujun Xu, Ping Li, Li Liu, Xiaodong Liu	17
10	Bile duct ligation enhances AZT CNS toxicity partly by impairing the expression and function of BCRP in rat brain 2019 ·Acta Pharmacologica Sinica ·Yuanyuan Qin, Ping Xu, Tong Wu, (unknown), Yilin Fan, (unknown), Liang Zhu, Weimin Kong, Hanyu Yang, Feng Xu, (unknown), Li Liu, Xiaodong Liu	10
11	Impairment of Intestinal Monocarboxylate Transporter 6 Function and Expression in Diabetic Rats Induced by Combination of High-Fat Diet and Low Dose of Streptozocin: Involvement of Butyrate–Peroxisome Proliferator-Activated Receptor-γ Activation 2019 ·Drug Metabolism and Disposition ·Feng Xu, Liang Zhu, (unknown), Junjie Zhou, (unknown), Ping Li, Wenjing Xuan, (unknown), Kaijing Zhao, Weimin Kong, Yuanyuan Qin, Limin Liang, Li Liu, Xiaodong Liu	13
12	The non-psychoactive phytocannabinoid cannabidiol (CBD) attenuates pro-inflammatory mediators, T cell infiltration, and thermal sensitivity following spinal cord injury in mice 2018 ·Cellular Immunology ·Hongbo Li, Weimin Kong, (unknown), Daohai Yu, Doina Ganea, Ronald F. Tuma, Sara Jane Ward	58
13	Prostaglandin E2 Inhibition of IL-27 Production in Murine Dendritic Cells: A Novel Mechanism That Involves IRF1 2017 ·PMC ·(unknown), Jui‐Hung Yen, Weimin Kong, (unknown), Ping‐Chang Kuo, Ana M. Gamero, Doina Ganea	1
14	Protein tyrosine phosphatase σ regulates autoimmune encephalomyelitis development 2017 ·Brain Behavior and Immunity ·Yosuke Ohtake, Weimin Kong, Rashad Hussain, Makoto Horiuchi, Michel L. Tremblay, Doina Ganea, Shuxin Li	15
15	Prostaglandin E2 inhibits Tr1 cell differentiation through suppression of c-Maf 2017 ·PLoS ONE ·(unknown), Weimin Kong, Doina Ganea	20
16	The natural dual cyclooxygenase and 5-lipoxygenase inhibitor flavocoxid is protective in EAE through effects on Th1/Th17 differentiation and macrophage/microglia activation 2015 ·Brain Behavior and Immunity ·Weimin Kong, (unknown), Doina Ganea	41
17	Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS 2013 ·Cellular Immunology ·Weimin Kong, Hongbo Li, Ronald F. Tuma, Doina Ganea	76
18	IFN-β Inhibits Dendritic Cell Migration through STAT-1–Mediated Transcriptional Suppression of CCR7 and Matrix Metalloproteinase 9 2010 ·The Journal of Immunology ·Jui‐Hung Yen, Weimin Kong, Doina Ganea	60
19	Docosahexaenoic acid prevents dendritic cell maturation and in vitro and in vivo expression of the IL-12 cytokine family 2010 ·Lipids in Health and Disease ·Weimin Kong, Jui‐Hung Yen, Evros Vassiliou, Sabina Adhikary, Miguel G. Toscano, Doina Ganea	104
20	Docosahexaenoic acid prevents dendritic cell maturation, inhibits antigen-specific Th1/Th17 differentiation and suppresses experimental autoimmune encephalomyelitis 2010 ·Brain Behavior and Immunity ·Weimin Kong, Jui‐Hung Yen, Doina Ganea	106

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact